Glaxosmithkline Pharmaceuticals informs about postal ballot notice

30 Nov 2022 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Company had conducted the process of Postal Ballot through remote e-voting for seeking the consent of the shareholders by means of passing Ordinary Resolutions as for Appointment of Bhushan Akshikar (DIN: 09112346) as a Director; and Appointment of Bhushan Akshikar (DIN: 09112346) as Manaaina Director. In Compliance with the provisions of Regulations 44(3) of the LODR, Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management & Administration) Rules 2014 as amended and the applicable circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India the Company had provided voting facility to all its members to enable them to cast their vote on all matters listed in the Notice convening the Postal Ballot through electronic means during the period commencing from Monday 31st October2022 (09.00 am) and ended on Tuesday, 29th November 2022 (5.00 pm). In this Connection, it enclosed the following: Details regarding the voting results pursuant to Regulation 44(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015; and Scrutinizer Report. 

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

1859.90 -29.30 (-1.55%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.